Back to dashboard Episode 50

DIP Episode 50 - Comprehensive USMLE Biochemistry (Session 1 of 2)

MixedMedium4 - HighHas Q&A

Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3

Topic

Amino acid metabolism; Urea cycle regulation; Heme synthesis pathway disorders (Porphyrias); Glycolysis and glucose transport; Folate and B12 biochemistry.

Key Takeaway

The body manages excess nitrogen via the urea cycle, which is regulated by N-Acetylglutamate (NAG) and involves enzymes located in both the mitochondria and cytosol; metabolic pathways like heme synthesis and glycolysis are tightly controlled by allosteric regulation and specific transporters (e.g., GLUT2).

Runtime: — min

Published: 2018-09-25

Completed audio: Yes

Completed notes: Yes

Anki made: Yes

Section: BIOCHEMISTRY

Open Notion notes Episode source

Episode Notes

Source / episode info

Episode: 50
Title: Divine Intervention Episode 50 – Comprehensive USMLE Biochemistry (Session 1 of 2).
Published: 2018-09-25
Source: Episode page

One-liner

This episode provides a comprehensive review of core biochemistry topics, including the double-location urea cycle, amino acid disorders like PKU and homocystinuria, the rate-limiting steps and clinical manifestations of porphyrin synthesis defects, and the regulatory mechanisms governing glycolysis and glucose transport.

High-yield summary

Urea Cycle: The first two enzymatic steps (CPS1 and Citrulline Synthase) occur in the mitochondria, while the final steps occur in the cytosol. N-Acetylglutamate is an obligate activator of CPS1.
Protein Disorders: PKU involves defective phenylalanine hydroxylase (PAH), leading to a mousy odor; Alkaptonuria results from homogentisic acid oxidase deficiency, causing blue-black urine and ochronosis.
Folate/B12 Metabolism: Folate is required for pyrimidine synthesis (via thymidylate synthase). The conversion of storage folate to active folate requires methionine synthase, which necessitates Vitamin B12. Deficiency leads to megaloblastic anemia.
Heme Synthesis: ALAS is the rate-limiting enzyme, inhibited by heme. Porphyrias are categorized by location: AIP (PBGD deficiency) lacks photosensitivity; PCT (UROD deficiency) causes severe photosensitivity and hirsutism.
Glycolysis Regulation: Glucokinase has a high K_M and is induced by insulin, regulated by the GKRP. GLUT2 transporters operate on the "straight line" portion of the Michaelis-Menten curve due to their high K_M.

Learning objectives

Describe the metabolic fate of amino acids, including the role of the urea cycle in ammonia detoxification.
Differentiate between various inherited disorders of amino acid and porphyrin metabolism based on clinical presentation and biochemical markers.
Explain the regulatory mechanisms governing key pathways like glycolysis (e.g., Glucokinase regulation) and glucose transport (GLUT transporters).
Identify the cofactors required for critical enzymatic reactions, such as those in folate/B12 metabolism and heme synthesis.
Correlate metabolic defects with specific clinical findings, such as megaloblastic anemia or photosensitivity.

Board exam buzzwords

Condition	Key Finding	Association	Board Exam Tip
Phenylketonuria (PKU)	Mousey/Musty odor; elevated Phe	PAH deficiency	Requires dietary restriction of phenylalanine in infancy.
Alkaptonuria	Blue-black urine; Ochronosis	Homogentisic acid oxidase deficiency	The deposition process is key for diagnosis.
Porphyria Cutanea Tarda (PCT)	Photosensitivity, Hirsutism	UROD deficiency	Remember the "Tard" association with photosensitivity and Hep C risk.
Hemochromatosis	Iron overload; Liver cirrhosis	HFE mutation	Treatment is phlebotomy to reduce iron stores.

Rapid review table

Topic	Key Point	Context	Exam Relevance
Urea Cycle	NAG activates CPS1 (Mitochondria)	Detoxification of excess ammonia from protein catabolism.	Know the double location: Mitochondria -> Cytosol.
PKU/AA Disorders	PAH deficiency; elevated Phe	Inborn error of metabolism involving aromatic amino acids.	Must remember the specific odor and enzyme defect.
Heme Synthesis	ALAS is rate-limiting; inhibited by heme	Biosynthesis pathway for porphyrins required for hemoglobin.	Porphyrias are often triggered by drugs or fasting/stress.
Glycolysis Regulation	Glucokinase (high K_M) regulated by GKRP	Glucose uptake in the liver, ensuring proportional glucose clearance.	High K_M means it operates on the linear portion of the curve.

Board-speak -> diagnosis

Board-speak / Vignette phrase	Diagnosis / Concept	Why it fits
A patient presents with a mousy odor, intellectual disability, and is diagnosed with elevated plasma phenylalanine.	Phenylketonuria (PKU)	Defective PAH enzyme leads to accumulation of phenylalanine and its metabolites.
A young male develops dark urine and severe arthropathy years after initial symptoms, following an exposure to industrial chemicals.	Alkaptonuria	Accumulation of homogentisic acid, which polymerizes and deposits in connective tissues (ochronosis).
A patient presents with photosensitive skin lesions, hypertrichosis, and elevated uroporphyrin levels.	Porphyria Cutanea Tarda (PCT)	Caused by UROD deficiency; the buildup of porphyrins is photoactive.
A metabolic screen reveals elevated homocysteine and low B12/B6 status in a patient with megaloblastic anemia.	Folate-B12 Deficiency	Both deficiencies impair remethylation, leading to hyperhomocysteinemia and impaired DNA synthesis.
A patient has chronic iron overload due to genetic mutation affecting hepcidin regulation.	Hemochromatosis	HFE mutations lead to excessive intestinal absorption of iron, requiring phlebotomy for treatment.
A metabolic disorder presents with elevated plasma ammonia levels and requires administration of sodium phenylbutyrate or sodium benzoate.	Hyperammonemia/Urea Cycle Dysfunction	These agents act as nitrogen scavengers (e.g., forming phenylacetylglutamine) to bypass the impaired urea cycle.

Differential diagnosis / distinguishing features

Porphyrias (General)

Key Features	Distinguishing Findings	Next Step
Photosensitivity, hypertrichosis, uroporphyrin buildup	PCT (UROD deficiency): Most common; severe photosensitivity.	Avoid UV light and manage underlying triggers (e.g., Hep C).
Neuro symptoms, port-wine urine, no photosensitivity	AIP (PBGD deficiency): Affects the enzyme before uroporphyrinogen III formation.	Management is supportive; often related to specific metabolic blocks.

Glucose Transport/Enzymes

Key Features	Distinguishing Findings	Next Step
Low K_M, low VMAX; Hexokinase	High K_M, high VMAX; Glucokinase	Hexokinase is found in most tissues (e.g., brain); Glucokinase is specific to the liver.
Insulin-dependent translocation of vesicles	GLUT4 transporter	Muscle and adipose tissue uptake mechanism.

Management pearls

Hyperammonemia: Treat with nitrogen scavengers like sodium phenylbutyrate or sodium benzoate, which convert excess \text{NH}_3 into excretable compounds (e.g., hippurate).
Hemochromatosis Diagnosis: The initial step is usually a full iron panel and genetic testing for the HFE gene mutation. Treatment involves regular phlebotomy to reduce total body iron stores.
Porphyria Management: Avoid triggers like alcohol, certain medications (e.g., sulfonamides), and excessive UV exposure. For PCT, managing underlying liver disease is critical.
B12 Deficiency: If megaloblastic anemia is suspected, check serum B12 and folate levels; if low, administer parenteral B12 supplementation.

Don't miss

🚨

The urea cycle's double location (mitochondria for first two steps, cytosol for last two) is a high-yield concept.

🚨

\text{N}-Acetylglutamate (\text{NAG}) is the obligate allosteric activator of CPS1 .

🚨

In glycolysis, Glucokinase activity in the liver is regulated by GKRP binding to F6 P (inhibiting) or glucose (activating).

🚨

The absorption sites are specific: Iron in the duodenum; Folate in the duodenum/jejunum; \text{B}_{12} in the terminal ileum.

Integration & clinical reasoning

Pathology/Genetics: Many metabolic disorders discussed (PKU, Alkaptonuria) are classic examples of single enzyme deficiencies leading to toxic metabolite accumulation and secondary organ damage.
Pharmacology: Understanding cofactor requirements (\text{B}_6, \text{B}_{12}, Folate) is crucial for drug metabolism questions; deficiency can mimic the primary metabolic disorder.
Physiology/Endocrinology: The regulation of glucose uptake (GLUT4, insulin dependence) links biochemistry directly to endocrine function and exercise physiology.

OMM / COMLEX integration

🦴

For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.

Metabolic Crisis Management: In acute hyperammonemia, nitrogen scavengers are used to bind excess \text{NH}_3 and excrete it via urine/feces, bypassing the defective urea cycle.
Genetic Counseling: Many of these disorders (PKU, Hemochromatosis) have strong genetic components, making counseling essential for affected families.

Concept connections / cross-references

Episode 51: Focuses on renal physiology and acid-base balance, which relates to nitrogen excretion pathways.
No explicit cross-references.

High-yield association table

Condition	Association	Mechanism	Clinical Significance
PKU	Phenylalanine hydroxylase (PAH) deficiency	PAH converts Phe to Tyrosine; defect leads to accumulation of toxic metabolites.	Requires lifelong dietary restriction of phenylalanine.
Hemochromatosis	HFE gene mutation	Leads to excessive intestinal absorption and retention of iron.	Treatment is phlebotomy; risk of liver cirrhosis/endocrine failure.
Porphyria Cutanea Tarda (PCT)	UROD deficiency	Impaired conversion of uroporphyrinogen III -> uroporphyrinogen IV, leading to photoactive buildup.	Severe photosensitivity and hypertrichosis; risk associated with Hep C.
Homocystinuria	B6 or B12/Folate deficiency	Impaired remethylation of homocysteine back to methionine.	Causes megaloblastic anemia and vascular complications (e.g., Marfanoid habitus).

Key terms glossary

Term	Definition	Context	Example
N-Acetylglutamate (NAG)	Allosteric activator; a derivative of glutamate and acetyl-CoA.	Urea Cycle regulation.	High protein load leads to increased NAG, activating CPS1.
Glucokinase Regulatory Protein (GKRP)	Cytoplasmic protein that sequesters Glucokinase (GK).	Glycolysis/Glucose metabolism in the liver.	When bound by F6 P, GKRP inhibits GK; when bound by glucose, it releases GK to function.
Megaloblastic Anemia	Macrocytic anemia due to impaired DNA synthesis.	Folate or B12 deficiency.	Characterized by large, immature red blood cells (megaloblasts).
Ochronosis	Blue-black deposition of material in connective tissues.	Alkaptonuria.	Caused by the polymerization and deposition of homogentisic acid.

Study optimization

Topic	Study Approach	Priority	Resources
Metabolic Cycles (Urea, Heme)	Focus on rate-limiting enzymes, cofactors, and double locations.	High	Review the specific enzyme names and their mitochondrial/cytosolic location.
Amino Acid Disorders	Use mnemonics for odors (PKU -> mousy); link defects to clinical signs (Alkaptonuria -> blue-black).	Medium-High	Create flowcharts showing the metabolic block and the resulting toxic metabolite.
Carbohydrate Metabolism	Understand allosteric regulation (e.g., GKRP, PFK/F2,6 P) and transporter kinetics (K_M).	High	Practice drawing the regulatory steps for glycolysis in liver vs. muscle.

Question pattern recognition

The "Double Location" Trap: Identifying which enzymes operate in the mitochondria versus the cytosol (e.g., Urea Cycle).
Cofactor Deficiency Mimicry: Recognizing that multiple deficiencies (\text{B}_6, \text{B}_{12}, Folate) can cause similar clinical presentations (Homocystinuria, Megaloblastic Anemia).
Rate-Limiting Step Identification: Knowing which enzyme controls the flux through a pathway (e.g., ALAS in Heme Synthesis; Hexokinase/Glucokinase in Glycolysis).

Test yourself

Common mistakes to avoid

🚫

Confusing the roles of \text{B}_6 and \text{B}_{12} deficiency: Both cause hyperhomocysteinemia, but \text{B}_6 is needed for transsulfuration (cystathionine synthesis), while \text{B}_{12} is needed for remethylation.

🚫

Forgetting the double location of key cycles (Urea Cycle/Heme Synthesis).

🚫

Misremembering which transporter (K_M) dictates proportional glucose uptake in the liver (GLUT2).

Common traps

⚠️

The "Which deficiency causes X" trap: Always check if multiple deficiencies can cause similar findings (e.g., B9 vs \text{B}_{12} deficiency both causing megaloblastic anemia).

⚠️

The "What is the first step?" trap: For urea cycle, remember that CPS1 is the rate-limiting enzyme and requires NAG activation.

⚠️

The "Which disorder causes photosensitivity?" trap: PCT (UROD) is the most common porphyria associated with severe photosensitivity; AIP lacks this feature.

Original transcript with highlights

Divine Intervention Episode 50 Comprehensive Step 1 Biochemistry Review (Session 1) Some PGY1 Introduction -Primary goal is to review metabolism as relevant to Step 1. -My approach today will be to use a combo of questions AND mechanistic explanations of stuff to make you feel very comfortable with Step 1 metabolism. -Where appropriate, I’ll integrate Pharm, Pathology, and Physiology. -I am going to spend a lot of time going over how the material WILL be tested.

Intro To Nucleotide Synthesis

Pyrimidine and Purine Synthesis (+ The 2 Orotic Acidurias)

The Purine Salvage Pathway (+dATP and RR and SCID), Gout, Tumor Lysis Syndrome, 6-MP toxicity

Protein Digestion -Starts with the low pH environment of the stomach (denaturing) and the action of pepsin from chief cells. -Pancreas releases trypsin, chymotrypsin, carboxypeptidase, etc (to digest protein). The initial kickstarter for this process is enterokinase (working on trypsinogen). -A As are reabsorbed in single A As (and also as di/tripeptides, vs glucose). This requires Na symport. -HY disorders to know here include Hartnup disease (gut + renal neutral AA transport like tryptophan) AND Cystinuria (gut + renal basic AA transport like cysteine, can cause renal stones with a specific shape?? And can be treated with a drug??) Dealing With Our Protein Problem -We love protein as humans. However, they have a problem that we have to deal with on a daily basis (ammonia). We deal with this problem through the urea cycle and partially with ammonium excretion. -To make your life easy, think of the body having only 2 NH3 carriers (glutamine and alanine). The only source of alanine is muscle (why does this make sense?). -The kidney has an enzyme (glutaminase) to strip the NH3 off glutamine, add a H+, and then excrete the NH3 as NH4+. -The liver primarily forms urea (which can travel safely in the blood w/o trouble). Urea has 2 amino groups. These 2 amino groups come from 2 sources-> glutamate and aspartate. -If you understand these basics, the urea cycle becomes very doable. Go over it again! Relax, we’ll talk through this logically. Just summarizes what was on the previous slide.

The Urea Cycle Key Takeaways -There are only 2 enzymes you need to know in the urea cycle-CPS 1 and Ornithine Transcarbamylase. -Location matters here. First 2 steps are in the mitochondria. Final steps are in the cytosol. These “double location” details are HY for Step 1! -Primary regulation here is with N-Acetylglutamate being an obligate CPS1 activator (makes sense, NAG is something you’d potentially get from a “high protein meal”, taking in proteins should logically make you upregulate the pathway that deals with ammonia problems). -NH2 group #1 comes from Step 1. NH2 group #2 comes from Step 3 (aspartate). -Don’t forget your pesky arginine details (histones, NO synthesis). How would you manage hepatic encephalopathy?? The Urea Cycle

A Nice Step 1 Worthy Question. How would you differentiate between a UMP Synthase deficiency, a CPS1 deficiency, and an Ornithine Transcarbamylase deficiency? As an aside, what is the cofactor used quite extensively by transaminases? Carboxylases? Can you recall the enzymes used in the PDH complex? What are your B vitamins (and their other names)?

Protein Breakdown Diseases (super HY!) + VOMIT pathway -Remember your PKU and a mousy/musty odor (and PAH or THB reductase deficiency). Tyrosine becomes an essential AA. -Albinism is associated with a tyrosinase deficiency (tyrosine to melanin). -Alkaptonuria is associated with a homogentisic acid oxidase deficiency. Homogentisate makes urine blue black and causes joint disease (from deposition). -Branched chain ketoacid DH breaks down branched chain A As (LIV). A deficiency in this enzyme causes MSUD. This enzyme is also HY from the standpoint of some eerie relationship to the PDH complex and alpha ketoglutarate DH. -Homocystinuria (SH groups) can be caused by a CBS (B6) deficiency or a homocysteine methyltransferase (methionine synthase, B12) deficiency. What are 2 key details that differentiate this disorder from Marfan’s (think IQ and eye findings)? Protein Breakdown Disease Summary

Some Other HY AA Details Remember; GABA is made from glutamate by GAD (needs B6, autoantibodies in T1 DM) Tryptophan is a 5-HT (serotonin) and niacin precursor. Histamine is made from histidine (by histidine decarboxylase, scombroid association??) Vitamins and Minerals-Learn your vitamins and minerals in the context of folate metabolism and phenylalanine metabolism (contain most of the vitamin info you need for Step 1). -For phenylalanine metabolism, remember our stories with PKU, Albinism, Parkinson’s treatment, Vitamin C (and its role in collagen synthesis), PNMT and its special role in the adrenal medulla, and the HVA/VMA role in diagnosing a pheochromocytoma. -There are 2 KINDS of folate in the body -> active folate (AF, with a charged C) and storage folate (SF, with a methyl which is largely unreactive). All the fancy stuff folate does in the body is with its AF form. SF seems to be largely useless until you recognize one key fact -> It is a precursor to AF (with this irreversible interconversion carried out by homocysteine methyltransferase/methionine synthase, requires B12). -Folate is needed for pyrimidine synthesis (remember thymidylate synthase?). W/o DNA from folate, cells increase in size w/o “nuclear doubling” -> megaloblastic anemia. Tyrosine Metabolism and Parkinson’s Disease and PNMT

Folate and B12 Metabolism (Can you slot in the thymidylate synthase and DHFR inhibitors here???)

Another Step 1 Worthy Question (+ B12 depleting bug) B6 (Pyridoxal phosphate), B9 (Folate), and B12 (Cyanocobalamin) deficiencies can all cause homocystinuria. How would you differentiate b/w a B6 vs B9/12 deficiency as a cause of homocystinuria (think of the other elevated stuff)? After doing this, how would you differentiate b/w B9 and B12 deficiency as a cause of homocystinuria? What are the 2 classic NBME folate deficient patients?

The Heme Synthesis Pathway (+ avoiding barbiturates) -You need to know 5 enzymes in this pathway and some associated stories. -ALAS is the rate limiting enzyme (B6 cofactor, re-Isoniazid). It is inhibited by heme. -Pb poisoning (moonshine, old house) can cause a sideroblastic anemia with an increase in free erythrocyte protoporphyrin from ALAD and Ferrochelatase inhibition. Note your classic blood smear findings (+ neuro, + wrist drop, + abdominal pain). -A porphobilinogen deaminase deficiency is associated with AIP (no photosensitivity but neuro problems, port wine stained urine). So happens that Uroporphyrinogen 3 is the first porphyrin in this pathway and since it comes after PBGD, we don’t have a “photoactive” substance building up. -A UROD deficiency is associated with Porphyria Cutanea Tarda which does have photosensitivity (+ hirsutism, + Hep C association, + intense “hand” sweating). Heme Synthesis Pathway (Note the double location business going on here)

Another Step 1 Worthy Question How would you differentiate b/w Fe deficiency, Pb poisoning (just think of ferrochelatase), and B6 deficiency wrt FEP levels, ALA levels, ferritin levels, etc. Absorbing Fe/Breaking Down Heme -Fe is absorbed (also only carries O2) in the 2+ form only. Vit C encourages this process (what are 2 other HY functions of Vit C that have been discussed?). -HFE regulates this process. A HFE mutation can cause too much Fe reabsorption (hemochromatosis, tx w/phlebotomy). What should your first step in diagnosis be? -I’d encourage you to also try recalling the relationship b/w Fe2+/Fe3+ w/pathologies. -It is HY to know the breakdown pathway for heme and the different diseases that could arise from issues along that pathway (as well as the associated kind of hyperbilirubinemia)-> Hemolytic anemia, Newborn jaundice, TMP-SMX toxicity, Crigler Najjar (T1 and 2), Gilbert’s, Dubin Johnson, Rotor, Obstructive process, etc. -Remember that Fe is absorbed in the duodenum, folate is absorbed in duodenum/jejunum, B12 is absorbed in the terminal ileum (re-Crohn’s association). Heme Breakdown

Another Step 1 Worthy Question/Thought Can you explain these lesions? Option A-Increased urine bilirubin, decreased urine urobilinogen, increased direct bilirubin, dark/tea colored urine, acholic stools. Option B-Increased urine urobilinogen, no urine bilirubin, increased indirect bilirubin, normal colored urine, dark colored stools. Some General Principles (make thy life super easy!) -Insulin works through tyrosine kinase receptors. Insulin is a dephosphorylator. -Glucagon works through G protein coupled receptors which activate PKA. Glucagon is a phosphorylator. -If you know this, you can easily reason that if an enzyme is activated by insulin, the activated form must be a “dephosphorylated form” of the enzyme (and vice versa for glucagon). -Carboxylase enzymes are ABC enzymes (they use ATP and Biotin, hence the AB). C stands for carboxylase (and CO2). -Kinase enzymes as a rule add phosphate groups to stuff. GLUT Transporters

Other Important Stuff -As a correlation from prior blocks, remember that GLUT1 transporters operate under zero order kinetics by virtue of their low KM (approx. 5 mM) which tracks along with normal blood glucose levels. -GLUT 2 transporters have a KM that is much higher than normal blood glucose levels. If you consider the Michaelis Menten curve, this is ideal b/c the transporters will operate on the “straight line” portion which essentially guarantees “proportional” glucose uptake that tracks along with blood glucose levels. -Why are GLUT2 transporters bidirectional? -GLUT4 transporters are insulin dependent. Muscle has the unique ability to express GLUT4 transporters in an “insulin independent” fashion in the setting of exercise. Glycolysis Broken Down Part 1

Glucokinase vs. Hexokinase -Hexokinase has a low KM and VMAX. -Glucokinase has a high KM and VMAX. Glucokinase is also induced by insulin. Glucokinase is regulated by a regulatory protein under the auspices of F-6-P and glucose. Glucokinase Regulatory Protein -Is an inhibitor of glucokinase (GK). -Binds GK and sends it to the nucleus (where it is inactive). -GKRP has the ability to bind both F6 P and glucose. -When bound by F6 P, GKRP has a higher affinity for GK (which sequesters GK by taking it to the nucleus). -When bound by glucose, GKRP has a much lower affinity for GK (which brings it back to the cytoplasm for reaction). Glycolysis Broken Down Part 2

Glycolysis Broken Down Part 3

Glycolysis Broken Down Part 4

Some Other Important Stuff -Overall, glycolysis gives rise to the rule of 2s (2 AT Ps, 2 NADH, and 2 Pyruvates). Pyruvate has multiple fates; -It can form lactate under the action of lactate DH. This step regenerates NAD to keep the Glyceraldehyde-3-P DH step working. -Pyruvate can go into mitochondria to receive special attention from the PDH complex ultimately leading to Acetyl-co A formation. -Pyruvate can receive special attention from Pyruvate carboxylase (what is a HY cofactor utilized by this enzyme???) to form OAA that can reverse course in gluconeogenesis (through subsequent PEPCK action). References -First Aid for The USMLE Step 1 2018

Practice questions — USMLE style

Question 1 — Metabolism

A 35-year-old man presents to the emergency department with acute onset of photosensitivity, hirsutism, and severe hand sweating. His urine contains dark, tea-colored pigment, and a metabolic workup reveals elevated levels of uroporphyrin precursors. Which enzyme deficiency is most likely responsible for this constellation of findings?

A) Acute Intermittent Porphyria (AIP), due to porphobilinogen deaminase deficiency
B) Erythropoietic Protoporphyria, due to ferrochelatase deficiency
C) Porphyria Cutanea Tarda (PCT), due to uroporphyrinogen decarboxylase deficiency
D) Sideroblastic anemia, due to ALAS inhibition

Answer: C. The clinical presentation of photosensitivity, hirsutism, and intense sweating strongly suggests Porphyria Cutanea Tarda (PCT). PCT is caused by a deficiency in uroporphyrinogen decarboxylase (UROD), which leads to the accumulation of porphyrins that are highly susceptible to light damage. AIP (A) typically presents with severe abdominal pain and neurological symptoms, but lacks photosensitivity. Sideroblastic anemia (B) involves iron deposition and is not primarily linked to this specific set of cutaneous/photosensitive findings.

Question 2 — Biochemistry

A patient presents with elevated plasma homocysteine levels and signs of peripheral neuropathy. Laboratory testing reveals that the deficiency is due to impaired conversion of methylmalonyl-CoA to succinyl-CoA, leading to accumulation of methylmalonic acid (MMA). Which vitamin deficiency is responsible for this metabolic derangement?

A) Pyridoxine (Vitamin B6), impairing transamination
B) Folate (Vitamin B9), inhibiting thymidylate synthase
C) Cobalamin (Vitamin B12), required by methionine synthase
D) Niacin (Vitamin B3), necessary for NAD+ regeneration

Answer: C. The accumulation of methylmalonic acid and elevated homocysteine are classic findings associated with Vitamin B12 deficiency. Vitamin B12 is a cofactor for methionine synthase, which converts homocysteine back to methionine. Furthermore, B12 is required by methylmalonyl-CoA mutase (which requires adenosylcobalamin), making it essential for the breakdown of MMA. Pyridoxine (B6) deficiency typically causes elevated homocysteine but does not cause MMA accumulation.

Question 3 — Metabolism

A neonate presents with severe hyperammonemia and lethargy shortly after birth. Biochemical analysis reveals that the patient has a defect in the enzyme Ornithine Transcarbamylase (OTC). Given the metabolic pathway, which of the following statements accurately describes the primary consequence of this deficiency?

A) The inability to convert excess amino acids into urea leads to systemic nitrogen buildup.
B) Ammonia is primarily cleared by converting glutamate and aspartate into ureido groups in the cytosol.
C) Since OTC catalyzes a mitochondrial reaction, the resulting metabolic block prevents the formation of citrulline.
D) The primary defect causes an accumulation of ornithine within the mitochondria, leading to secondary renal tubular acidosis.

Answer: C. Ornithine Transcarbamylase (OTC) is crucial for the urea cycle and functions in the mitochondrial matrix. It catalyzes the reaction that combines carbamoyl phosphate with ornithine to form citrulline. A deficiency here causes a metabolic block before citrulline can be formed, leading to massive hyperammonemia because ammonia cannot be efficiently converted into urea. The accumulation of precursors (like carbamoyl phosphate) and the inability to proceed past this step are key features.

Question 4 — Physiology

A glucose transporter protein is responsible for maintaining stable blood glucose levels by having a high Michaelis constant ($K_M$) relative to normal plasma glucose concentrations. This characteristic allows the transporter to operate in a linear, proportional manner across the physiological range of blood sugar. Which GLUT transporter fits this description?

A) GLUT1 (found ubiquitously)
B) GLUT2 (primarily found in liver and pancreas)
C) GLUT3 (highly expressed in neurons)
D) GLUT4 (insulin-dependent muscle/adipose tissue)

Answer: B. GLUT2, found prominently in the liver and pancreatic beta cells, has a high $K_M$ (approximately 15 mM). This means that even when blood glucose levels rise significantly above normal, the transporter operates on the linear portion of the Michaelis-Menten curve. This proportional uptake is ideal for organs like the liver, allowing them to efficiently buffer and track changes in systemic blood glucose levels. GLUT1 has a low $K_M$ (high affinity) and tracks with general tissue needs; GLUT3 also has a very low $K_M$, making it highly sensitive to even minor drops in glucose.

Quick fire review

What two enzymes are critical to know in the urea cycle?

CPS1 (Carbamoyl Phosphate Synthetase I) and Ornithine Transcarbamylase (OTC).

Where do the first two steps of the urea cycle occur?

In the mitochondria.

Which amino acid disorder is associated with a "mousy/musty" odor due to PAH deficiency?

Phenylketonuria (PKU).

What specific cofactor is required for Pyruvate carboxylase activity?

Biotin.

What are the two key details that differentiate Homocystinuria from Marfan’s syndrome?

Elevated homocysteine and potential IQ/eye findings.

Which transporter operates under zero-order kinetics due to its low Km (approx 5 mM)?

GLUT1.

What is the obligate activator of CPS1 in the urea cycle, and why does this make sense?

N-Acetylglutamate (NAG); it logically upregulates the pathway when high protein intake increases ammonia load.

Which amino acid breakdown disorder results from a deficiency in Homogentisic Acid Oxidase, causing blue-black urine and joint deposition?

Alkaptonuria.

What is the primary difference between active folate (AF) and storage folate (SF)?

AF has a charged C group and is metabolically active; SF has a methyl group and is largely unreactive until converted to AF by methionine synthase/B12.

Which specific blood smear finding is associated with lead poisoning due to inhibition of ferrochelatase?

Increased free erythrocyte protoporphyrin (FEP).

What are the two classic folate deficient patients that present with megaloblastic anemia?

Pregnancy and veganism/malabsorption.

How does insulin signaling regulate enzyme activity, compared to glucagon signaling?

Insulin acts as a dephosphorylator (activating enzymes by removing phosphate); Glucagon activates PKA, acting as a phosphorylator (activating enzymes by adding phosphate).

Quick recall / Anki-style questions